Litcius/Paper detail

Use of a meningococcal group B vaccine (4CMenB) in populations at high risk of gonorrhoea in the UK

Shamez Ladhani, Peter J White, Helen Campbell, Sema Mandal, Ray Borrow, Nick Andrews, Sunil Bhopal, John Saunders, Hamish Mohammed, Lana Drisdale-Gordon, Emma Callan, Katy Sinka, Kate Folkard, Helen Fifer, Mary Ramsay

2024The Lancet Infectious Diseases39 citationsDOI

Topics & Concepts

MedicineObservational studyMeningococcal diseaseEpidemiologyMeningococcal vaccinePublic healthGonorrheaPopulationFamily medicineVaccinationNeisseria gonorrhoeaeEnvironmental healthNeisseria meningitidisVirologyImmunologyInternal medicineImmunizationMicrobiologyBiologyNursingAntigenGeneticsBacteriaHuman immunodeficiency virus (HIV)Bacterial Infections and VaccinesReproductive tract infections researchPneumonia and Respiratory Infections
Use of a meningococcal group B vaccine (4CMenB) in populations at high risk of gonorrhoea in the UK | Litcius